Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Feb 14, 2020; 26(6): 645-656
Published online Feb 14, 2020. doi: 10.3748/wjg.v26.i6.645
Table 1 Demographic and clinical characteristics, laboratory tests, and severity scores of patients on admission
CharacteristicAll patients (n = 1281)Without BI (n = 921)With BI (n = 360)P value
Median age (IQR) -yr51 (42-57)52 (43-57)50 (42-57)0.16
Male sex (%)1012 (79)726 (78.8)286 (79.4)0.88
Concomitant etiology of cirrhosis (%)
Alcohol142 (11.1)102 (11.1)40 (11.1)1.00
Others48 (3.7)36 (3.9)12 (3.3)0.74
HBeAg positive HBV (%)1421/1122 (37.5)298/794 (37.5)123/328 (37.5)1.00
Experience of anti-HBV treatment (%)1284/1176 (24.2)183/851 (21.5)101/325 (31.1)< 0.001
Decompensations (%)2
Ascites1099 (85.8)773 (83.9)326 (90.6)< 0.01
Jaundice534 (41.7)297 (32.2)237 (65.8)< 0.001
Gastrointestinal variceal bleeding336 (26.2)280 (30.4)56 (15.6)< 0.001
Hepatic encephalopathy190 (14.8)82 (8.9)108 (30)< 0.001
ACLF at admission (%)284 (22.2)130 (14.1)154 (42.8)< 0.001
Median value for laboratory tests (IQR)
Log10 HBV DNA (copies/mL)34.7 (3.1-6.1)4.8 (3-6.2)4.6 (3.1-5.7)0.33
Hemoglobin (g/L)103 (83-121)102 (82-119)107 (87-127)< 0.001
White cell count: × 109 cells/L4.7 (2.9-7.5)4.2 (2.7-6.1)6.9 (4.3-10.9)< 0.001
Platelet count: × 109 cells/L63 (40-102)60 (40-96)70 (42-117.5)< 0.01
International normalized ratio1.6 (1.3-2)1.4 (1.3-1.9)1.8 (1.5-2.6)< 0.001
Serum sodium (mmol/L)136 (131.2-139)136 (132.3-139.3)134 (129-137)< 0.001
Serum creatinine (mg/dL)0.8 (0.7-1)0.8 (0.7-1)0.8 (0.6-1.1)0.20
Aspartate aminotransferase (IU/L)67 (42-124)60 (40-107)97 (56.5-192)< 0.001
Alanine aminotransferase (IU/L)47 (30-97)42 (29-80)67 (37-185.8)< 0.001
Total bilirubin (mg/dL)3.4 (1.5-15.5)2.6 (1.4-8)10.9 (3-27.4)< 0.001
Serum albumin (g/dL)2.8 (2.5-3.2)2.9 (2.5-3.3)2.8 (2.4-3.1)< 0.001
Median value for severity scores (IQR)
Child-Pugh11 (9-12)10 (8-12)12 (10-13)< 0.001
MELD16.8 (11.8-25.5)14.8 (11.1-22.3)24.4 (17.1-30.2)< 0.001